28% Weight Loss on Retatrutide AND Protect Muscle? | Ep 477

Is retatrutide, the new triple agonist GLP-1, the next big thing in weight loss (or even rapid fat loss)? That depends on how the drug works, what the results are, the reality between the headlines and the evidence, and what happens to your weight when you stop. This episode breaks down retatrutide, the GLP-1, GIP, and glucagon triple agonist behind the largest weight loss numbers ever recorded in this class. It covers the Phase 2 obesity trial and the Phase 3 Triumph results, plus why cross-...